Wednesday , October 18 2017
Home / Resources / Clinical Presentations / SGLT-2 Inhibitors: A New Modality for Treating Type 2 Diabetes

SGLT-2 Inhibitors: A New Modality for Treating Type 2 Diabetes

In this set of Homerun Slides, we give you a brief overview of the functioning of this new class of drugs, and get into the specifics of the first drug in its class approved by the FDA, canagliflozin (Invokana)….

Link to download (.ppt format): SGLT-2 Inhibitors: A New Modality for Treating Type 2 Diabetes

See more SGLT-2 Resources